Changning Wang won the Ken Griffin Alpha-synuclein Imaging Competition and received substantial funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The team plans to identify new leads using a high-throughput screen of a large DNA-encoded library. This is a novel approach that will enable the screening of billions of small molecules in a short period of time and introduce diversity into the potential tracers in development. Once the team has identified potential leads, they plan to begin development and validation, including in postmortem tissue and patient-matched stem-cell models.